OpenAI’s Latest Model Is Designed to Extend Human Life by Re-Engineering Proteins

OpenAI is now trying to revolutionize the world of tech by training a new model that it says can extend human life.

Under the supervision of CEO Sam Altman, the new model dubbed GPT-4b micro collaborates with Retro Biosciences which is a longevity startup that is trying to extend the human lifespan by up to 10 years. They make use of biotechnology through the reengineering of proteins and make this effect come into play.

Retro is again supported by the OpenAI CEO and has been working closely alongside OpenAI for a good year now on this particular revolutionary technology. The micro model attacks a certain kind of protein called Yamanaka factors that transform human skin into a more youthful stem cell collection. Therefore, it feels strongly about how such proteins are a great step in designing human organs and giving rise to the supply of new or replacement cells.

The model is a little different from what we saw Android maker Google rollout in the form of AlphaFold which also got the Nobel Peace Prize. That model can accurately predict the outline of proteins but this new model from OpenAI is the first of its kind. It’s solely designed for biological research.

As per the MIT Technology Review, the release from OpenAI and Retro will first arise in the form of research for this model and its desired outputs.

Image: DIW-Aigen

Read next: Critics Call TikTok Ban a ‘Phobia,’ Urge Focus on Broader Big Tech Risks
Previous Post Next Post